Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Altmueller, Janine Dr.med. (29) Blankenstein, Thomas Prof. Dr. (9) Bunse, Mario Dr. (1) Fischer, Cornelius Dr. (1) Harabula, Izabela-Cezara (1) Kammertöns, Thomas Dr. (1) Kieback, Elisa Dr. (2) Lupianez Garcia, Dario Jesus Dr. (1) Schlag, Peter M. Prof. Dr. (1) Uckert, Wolfgang Prof. Dr. (3) Willimsky, Gerald Dr. (2) (-) Leisegang, Matthias Prof. Dr. rer. nat. (1) 2006 (1) (-) 2008 (1) 2010 (1) 2011 (1) (-) 2016 (2) 2017 (1) 2018 (2) 2020 (1) Cellular Neurosciences (2) Computational Regulatory Genomics (1) Experimental Ultrahigh-Field MR (4) Genome Engineering & Disease Models (2) Immune Regulation and Cancer (3) Magnetic Resonance (4) (-) Molecular Immunology and Gene Therapy (3) Proteome Dynamics (1) RNA Biology and Posttranscriptional Regulation (1) Transgenics (2) 3 Results: Active Filter: Leisegang, Matthias Prof. Dr. rer. nat.Molecular Immunology and Gene Therapy20082016 Sort: Result score Newest to oldest Oldest to newest July 07, 2008 / J Exp Med Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness G. Willimsky M. Czeh C. Loddenkemper J. Gellermann K. Schmidt P. Wust H. Stein T. Blankenstein October 17, 2016 / J Exp Med Preventing tumor escape by targeting a post-proteasomal trimming independent epitope A. Textor K. Schmidt P.M. Kloetzel B. Weißbrich C. Perez J. Charo K. Anders J. Sidney A. Sette T.N.M. Schumacher C. Keller D.H. Busch U. Seifert T. Blankenstein March 01, 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein
July 07, 2008 / J Exp Med Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness G. Willimsky M. Czeh C. Loddenkemper J. Gellermann K. Schmidt P. Wust H. Stein T. Blankenstein
October 17, 2016 / J Exp Med Preventing tumor escape by targeting a post-proteasomal trimming independent epitope A. Textor K. Schmidt P.M. Kloetzel B. Weißbrich C. Perez J. Charo K. Anders J. Sidney A. Sette T.N.M. Schumacher C. Keller D.H. Busch U. Seifert T. Blankenstein
March 01, 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein